[1]Patent:WO2016/185342,2016,A1.Locationinpatent:Page/Pagecolumn39
[1]CurrentPatentAssignee:INCYTECORP-WO2019/79469,2019,A1Locationinpatent:Page/Pagecolumn160-161
[1]CurrentPatentAssignee:INCYTECORP-WO2019/79469,2019,A1
1159811-97-8
1276056-68-8
1208082-91-0
1330750-56-5
91225-51-3
1276056-84-8
1164457-90-2 | (E)-3-(1-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-indol-3-yl)acrylic acid | AA008V02 | MFCD00664519
1042628-16-9 | (2-(sec-Butoxy)phenyl)methanamine | AA008V6Y | MFCD11053944
1119451-03-4 | 2-(2-Ethyl-1H-imidazol-1-yl)acetonitrile | AA008VBG | MFCD12026943
1073556-04-3 | 3-butyl-1-methylpiperazin-2-one | AA008VHC | MFCD08060031
1060807-48-8 | 4-Chloro-6-(trifluoromethyl)nicotinaldehyde | AA008VNP | MFCD13188806
1061214-09-2 | 4-[[3-(4-Methylphenyl)-3-oxo-1-(trifluoroMethyl)propylidene]aMino]benzenesulfonaMide | AA008VV4 | MFCD32069550
1001648-73-2 | 2-Amino-6-bromo-5,6-dihydrobenzo[d]thiazol-7(4H)-one | AA008W2Q | MFCD19442517
1093679-71-0 | Caffeic Acid 4-β-D-Glucuronide | AA008WEX | MFCD30186676
1134635-03-2 | Galnac beta(1-3)gal alpha(1-4)gal beta(1-4)glc-beta-pnp | AA008WMP | MFCD15072174
1135339-49-9 | rac-2,3-Dehydro-3,4-dihydro IverMectin | AA008WV6